Industry & ResearchResearch News
Global pharma buys Covid-era UQ technology for $1.6bn
Sanofi has bought the company developing UQ’s proprietary Molecular Clamp vaccine platform
Breakthrough vaccine technology invented by the University of Queensland is at the centre of a landmark deal worth up to $1.6bn struck with global pharmaceutical giant Sanofi.
Please login below to view content or subscribe now.
